Key Studies Influencing My Practice Following IAS 2021

July 18-21, 2021; Virtual
Read expert faculty members’ summaries of key studies from this important annual conference, including new data on the following hot topics: HIV PrEP; 2-drug regimen ART; ART in children and adolescents; long-acting ART; investigational ART; treatment strategies for cryptococcal meningitis and drug resistant tuberculosis; and COVID-19 outcomes in people with HIV.
Daniel R. Kuritzkes, MD
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Babafemi Taiwo, MBBS
Format: Microsoft PowerPoint (.ppt)
File Size: 671 KB
Released: August 5, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Related Content

Dr. Samantha Strong shares key data and recommendations to consider when choosing a PrEP option for a cisgender woman, from Clinical Care Options (CCO)

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 6, 2022 Expired: October 5, 2023

Expert insights on ART management, guideline updates, and resistance analysis, from Dr Eric S. Daar and Clinical Care Options (CCO)

Eric S. Daar, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Pharmacists: 1.0 contact hour (0.1 CEUs) Released: October 6, 2022 Expired: October 5, 2023

Clinical Care Options (CCO) slideset providing expert insights for ART management in complex clinical situations, including extensive previous treatment

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Eric S. Daar, MD
Released: October 6, 2022

Slides on ART management, guideline updates, and resistance analysis, from Dr Eric S. Daar and Clinical Care Options (CCO)

Eric S. Daar, MD Released: October 5, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings